previous compound ID: 710 next compound
InChIKey: GHUUBYQTCDQWRA-UHFFFAOYSA-N
SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "DY Thomas" "R Robert" "JW Hanrahan" "E Matthes" "D Rotin" "B Kus" "GW Carlile" "J Liao" "SD Macknight"

chemical graph of compound 710





CID is 60560
synonyms found at PubChem are:
pioglitazone hydrochloride, 112529-15-4, Pioglitazone HCl, 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride, U-72107A, Pioglitazone (hydrochloride), Pioditazone hydrochloride, [5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride, NCGC00095131-01, U-72107E, (+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride, DSSTox_CID_24203, DSSTox_RID_80116, C19H21ClN2O3S, DSSTox_GSID_44203, Piomed, 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione HCl, 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride, 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrochloride, 2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-, 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, monohydrochloride, SMR000469167, CAS-112529-15-4, 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hcl, 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hydrochloride, 5-[4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl]-thiazolidine-2,4-dione hydrochloride, 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride, Pioglitazone hydrochloride [USAN], 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride, 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride, Pioglitazone hydrochloride [USAN:USP], AC1L1THE, pioglitazone, hydrochloride, AC1Q6GK5, CHEMBL1715, SCHEMBL21843, C19H20N2O3S.HCl, MLS001306462, MLS001401386, SPECTRUM1504401, CHEBI:8229, DTXSID3044203, Pioglitazone Hydrochloride ,(S), CTK8B3228, GHUUBYQTCDQWRA-UHFFFAOYSA-N, MolPort-003-666-558, MolPort-027-851-177, HMS1922L05, Pioglitazone hydrochloride (Actos), ACT04238, BCP22942, KS-00000IO7, Tox21_111440, Tox21_300584, ANW-42027, CCG-39097, CP0139, MFCD04975446, s2046, AKOS015844016, Tox21_111440_1, AC-1037, CCG-100931, CS-2235, KS-1186, MCULE-1259842295, NC00181, Pioglitazone hydrochloride (JP17/USP), RTR-001112, NCGC00095131-02, NCGC00163128-08, NCGC00254492-01, AA-10090, AN-15335, BC204340, BR-50391, CPD000469167, HY-14601, I868, SAM001246600, SC-19064, BCP0726000151, AB0013914, AB1009260, LS-151328, LS-172192, Pioglitazone hydrochloride, >=98% (HPLC), ST2411660, TL8000362, TR-001112, AM20061770, FT-0082357, FT-0601607, P1901, 112529-15-4 (HCl), A-2403, D00945, J10107, 025P468, A802593, I06-0413, Q-201584, Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard, [(+-)-5-[[4-[4-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] monohydrochloride, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, hcl, 5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride, 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride, 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride, 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride, Pioglitazone for system suitability, European Pharmacopoeia (EP) Reference Standard, Pioglitazone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 127676-30-6, 2,4-thiazolidinedione,5-((4-(2-(5-ehtyl-2-pyridinyl)ethoxy)phenyl)methyl)-monohydrochloride, Pioglitazone hydrochioride, AKOS026749830, Pioglitazone hydrochloride, 98% 250mg, Pioglitazone hydrogen chloride